H

Hopstem Biotechnology Co., Ltd.

10 employees

Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
ESCs and other cell lines
human astrocytes
3D brain organoids
Organ-on-chips
human progenitor cells
human dopamine neurons
human CNs differentiation kit
dsRED line establishment
human MNs differentiation kit
human motor neurons
human cortical neurons
knockin and gene editing of human iPSCs
human DNs differentiation kit
human neuron maturation kit
knockout
Human neuron cryopreserve solution
human striatal neuron differentiation kit
Health Care
human neural stem cells
Human NSCs and NPCs cryopreserve solution
human astrocytes differentiation kit
Transposon-based GFP
human iPSCs

Date founded

2017

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

H

Hopstem Biotechnology Co., Ltd. raised $40M on October 31, 2021

Investors: Lilly Asia Ventures

FAQ